Edesa Biotech, Inc. - 8-K Filing
European Commission grants orphan drug designation to paridiprubart for Acute Respiratory Distress Syndrome (ARDS) treatment. (Items: 8.01 Other Events)
European Commission grants orphan drug designation to paridiprubart for Acute Respiratory Distress Syndrome (ARDS) treatment. (Items: 8.01 Other Events)